Panelist Diaries: What makes a good endpoint in cancer management?
In Plato’s book, The Theaetetus, Socrates was at wrestling school, discussing what he believed ‘knowledge’ to be to his...
Cancer vaccines in the clinic and in trials
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
Pembrolizumab for HER2 Positive Gastric Cancer
The Food and Drug Administration grants accelerated approval to Merck’s Keytruda (pembrolizumab), the checkpoint inhibitor drug for HER2-positive gastric...
First-in-class drug approved for bone marrow protection during chemotherapy
Chemotherapy can be lifesaving, but it can also damage bone marrow and cause blood cell counts to drop, sometimes...
Circadian Clock Protein CRY1 – The Novel Target for Prostate Cancer
Prostate cancer is one of the most common cancers and a second leading cause of cancer death in American...
Bispecific antibodies are progressing in cancer clinical trials
The human immune system makes antibodies that bind to the same antigen with both of their variable regions, or...
CRISPR-Based Diagnostics on the Rise
In 2020, the Nobel Prize in Chemistry was awarded for “the development of a method for genome editing” based...
The Human Microbiome and the cancer
The interaction of the human microbiome and cancer has been of great interest recently. Two articles published in February...
Ovarian Cancer: What We Know So Far, What’s the Status?
September is considered as the National Ovarian Cancer Awareness month. Each year, the scientific community gathers more information about...
Advancements in Cancer Imaging: Are Patients Reaping the Rewards?
Successful cancer treatment relies heavily on timely and accurate diagnosis and continued response assessment. The quality of the information...